Pricing Log in Create free account
Friday 6 November 2026 Export CLDX’s income statement to Excel — free account

Celldex Therapeutics, Inc.

CLDX Healthcare Biotechnology

Celldex Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 million, down 78.0% from fiscal 2024.

Revenue
−96.8%
EPS
−10.6%
Free cash flow
−35.5%

Quarter to June 2026, against a year earlier

29.90 1.63 +5.77%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−7.2×
Dividend yield
—
F-score
2/9
Altman Z
14.41
Beneish M
6.76
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Celldex Therapeutics, Inc. (CLDX) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Celldex Therapeutics, Inc. (CLDX) trades at a P/S ratio of 2,498×. Over the past ten years it has ranged from 2.8× (December 2018) to 3,938× (August 2026); the current reading is higher than 97% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 663× 186.12%
FY2024 232× (18.51%)
FY2023 284× (67.05%)
FY2022 863× 142.35%
FY2021 356× 408.77%
FY2020 70.0× 673.17%
FY2019 9.1× 178.46%
FY2018 3.3× (88.96%)
FY2017 29.5× (45.47%)
FY2016 54.0× (80.56%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 3,265× 141.26%
Mar 2026 1,354× 104.07%
Dec 2025 663× 184.28%
Jun 2025 233× 46.37%
41 more quarters

Against its own ten years

Low 2.8× High 3,938×
Ten-year median 199×
Current reading's percentile 97

P/S ratio against peers

Company P/S ratio
PHVS Pharvaris N.V. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
BHVN Biohaven Ltd. compare 2.1×
ADMA ADMA Biologics Inc compare 5.7×
AUPH Aurinia Pharmaceuticals Inc compare 6.7×
VCEL Vericel Corporation compare 8.1×
PVLA Palvella Therapeutics, Inc. compare 54.1×
IMNM Immunome, Inc. compare 162×
CLDX Celldex Therapeutics, Inc. 2,498×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on CLDX